184 related articles for article (PubMed ID: 21112399)
1. Genome-wide gene expression and promoter binding analysis identifies NFIL3 as a repressor of C/EBP target genes in neuronal outgrowth.
MacGillavry HD; Cornelis J; van der Kallen LR; Sassen MM; Verhaagen J; Smit AB; van Kesteren RE
Mol Cell Neurosci; 2011 Feb; 46(2):460-8. PubMed ID: 21112399
[TBL] [Abstract][Full Text] [Related]
2. NFIL3 and cAMP response element-binding protein form a transcriptional feedforward loop that controls neuronal regeneration-associated gene expression.
MacGillavry HD; Stam FJ; Sassen MM; Kegel L; Hendriks WT; Verhaagen J; Smit AB; van Kesteren RE
J Neurosci; 2009 Dec; 29(49):15542-50. PubMed ID: 20007478
[TBL] [Abstract][Full Text] [Related]
3. A role for nuclear factor interleukin-3 (NFIL3), a critical transcriptional repressor, in down-regulation of periovulatory gene expression.
Li F; Liu J; Jo M; Curry TE
Mol Endocrinol; 2011 Mar; 25(3):445-59. PubMed ID: 21212137
[TBL] [Abstract][Full Text] [Related]
4. Genetic Deletion of the Transcriptional Repressor NFIL3 Enhances Axon Growth In Vitro but Not Axonal Repair In Vivo.
van der Kallen LR; Eggers R; Ehlert EM; Verhaagen J; Smit AB; van Kesteren RE
PLoS One; 2015; 10(5):e0127163. PubMed ID: 25993115
[TBL] [Abstract][Full Text] [Related]
5. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
[TBL] [Abstract][Full Text] [Related]
6. NFIL3 is a negative regulator of hepatic gluconeogenesis.
Kang G; Han HS; Koo SH
Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537
[TBL] [Abstract][Full Text] [Related]
7. Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.
Liu TT; Kim S; Desai P; Kim DH; Huang X; Ferris ST; Wu R; Ou F; Egawa T; Van Dyken SJ; Diamond MS; Johnson PF; Kubo M; Murphy TL; Murphy KM
Nature; 2022 Jul; 607(7917):142-148. PubMed ID: 35732734
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for specific DNA sequence recognition by the transcription factor NFIL3.
Chen S; Lei M; Liu K; Min J
J Biol Chem; 2024 Mar; 300(3):105776. PubMed ID: 38382670
[TBL] [Abstract][Full Text] [Related]
9. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
10. Identification of the role of C/EBP in neurite regeneration following microarray analysis of a L. stagnalis CNS injury model.
Aleksic M; Feng ZP
BMC Neurosci; 2012 Jan; 13():2. PubMed ID: 22217148
[TBL] [Abstract][Full Text] [Related]
11. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
[TBL] [Abstract][Full Text] [Related]
12. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
[TBL] [Abstract][Full Text] [Related]
13. A distal region involving hepatocyte nuclear factor 4alpha and CAAT/enhancer binding protein markedly potentiates the protein kinase A stimulation of the glucose-6-phosphatase promoter.
Gautier-Stein A; Mithieux G; Rajas F
Mol Endocrinol; 2005 Jan; 19(1):163-74. PubMed ID: 15388792
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of mouse germline Ig gamma 1 and epsilon promoters by IL-4 and CD40.
Mao CS; Stavnezer J
J Immunol; 2001 Aug; 167(3):1522-34. PubMed ID: 11466373
[TBL] [Abstract][Full Text] [Related]
15. Cyclic adenosine 3',5'-monophosphate response element-binding protein and CCAAT/enhancer-binding protein mediate prostaglandin E2-induced steroidogenic acute regulatory protein expression in endometriotic stromal cells.
Hsu CC; Lu CW; Huang BM; Wu MH; Tsai SJ
Am J Pathol; 2008 Aug; 173(2):433-41. PubMed ID: 18583320
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Mapping of DNA Accessibility and Binding Sites for CREB and C/EBP
Jung HJ; Raghuram V; Lee JW; Knepper MA
J Am Soc Nephrol; 2018 May; 29(5):1490-1500. PubMed ID: 29572403
[No Abstract] [Full Text] [Related]
17. Identification of neuronal target genes for CCAAT/enhancer binding proteins.
Kfoury N; Kapatos G
Mol Cell Neurosci; 2009 Mar; 40(3):313-27. PubMed ID: 19103292
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of the Xenopus CCAAT-enhancer binding protein beta gene promoter.
Foka P; Kousteni S; Ramji DP
Biochem Biophys Res Commun; 2001 Jul; 285(2):430-6. PubMed ID: 11444861
[TBL] [Abstract][Full Text] [Related]
19. 3',5'-cyclic adenosine monophosphate response element-binding protein and CCAAT enhancer-binding protein are dispensable for insulin inhibition of phosphoenolpyruvate carboxykinase transcription and for its synergistic induction by protein kinase A and glucocorticoids.
Yeagley D; Quinn PG
Mol Endocrinol; 2005 Apr; 19(4):913-24. PubMed ID: 15604115
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).
Parkin SE; Baer M; Copeland TD; Schwartz RC; Johnson PF
J Biol Chem; 2002 Jun; 277(26):23563-72. PubMed ID: 11980905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
